Actinium Pharmaceuticals, Inc. Quarterly Revenues in USD from Q2 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Actinium Pharmaceuticals, Inc. annual/quarterly Revenues history and growth rate from Q2 2011 to Q4 2022.
  • Actinium Pharmaceuticals, Inc. Revenues for the quarter ending December 31, 2022 was $0.000, a 100% decline year-over-year.
  • Actinium Pharmaceuticals, Inc. Revenues for the twelve months ending December 31, 2022 was $1.03M, a 9.97% decline year-over-year.
  • Actinium Pharmaceuticals, Inc. annual Revenues for 2023 was $81K, a 92.1% decline from 2022.
  • Actinium Pharmaceuticals, Inc. annual Revenues for 2022 was $1.03M, a 9.97% decline from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $1.03M $0 -$23K -100% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $1.05M $45K -$188K -80.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.24M $45K -$221K -83.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.46M $940K +$318K +51.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.14M $23K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $233K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $266K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $622K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2012 $0 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $0 $0 Apr 1, 2012 Jun 30, 2012 10-Q/A 2012-08-29
Q3 2011 $0 Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $0 Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.